Junior Bravia 20mg Tablet contains Pantoprazole, a proton pump inhibitor used primarily to reduce gastric acid secretion. Each tablet delivers 20mg of Pantoprazole, making it suitable for pediatric patients requiring acid suppression therapy. The medication is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and conditions involving excessive stomach acid production, such as Zollinger-Ellison syndrome. Pantoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby blocking the final step of acid production. This results in decreased gastric acidity, promoting healing of acid-related damage and alleviating symptoms such as heartburn and acid regurgitation. Junior Bravia 20mg Tablet is generally well tolerated; however, potential adverse effects may include headache, abdominal pain, diarrhea, nausea, and dizziness. It is important to administer the tablet as prescribed by a healthcare professional, typically before meals for optimal efficacy. Caution is advised in patients with liver impairment, and long-term use should be monitored due to potential risks such as vitamin B12 deficiency and increased susceptibility to gastrointestinal infections. This medication should be used under medical supervision, with adherence to recommended dosing guidelines to ensure safety and therapeutic effectiveness.